The origins of African Plasmodium vivax; insights from mitochondrial genome sequencing.
Plasmodium vivax, the second most prevalent of the human malaria parasites, is estimated to affect 75 million people annually. It is very rare, however, in west and central Africa, due to the high prevalence of the Duffy negative phenotype in the human population. Due to its rarity in Africa, previo...
Guardado en:
Autores principales: | Richard Culleton, Cevayir Coban, Fadile Yildiz Zeyrek, Pedro Cravo, Akira Kaneko, Milijaona Randrianarivelojosia, Voahangy Andrianaranjaka, Shigeyuki Kano, Anna Farnert, Ana Paula Arez, Paul M Sharp, Richard Carter, Kazuyuki Tanabe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/baf92abfd1b0482bb149d1d6b0dfa317 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A systematic in silico search for target similarity identifies several approved drugs with potential activity against the Plasmodium falciparum apicoplast.
por: Nadlla Alves Bispo, et al.
Publicado: (2013) -
Plasmodium vivax infection compromises reticulocyte stability
por: Martha A. Clark, et al.
Publicado: (2021) -
Plasmodium vivax malaria endemicity in Indonesia in 2010.
por: Iqbal R F Elyazar, et al.
Publicado: (2012) -
Endothelial glycocalyx degradation and disease severity in Plasmodium vivax and Plasmodium knowlesi malaria
por: Bridget E. Barber, et al.
Publicado: (2021) -
Modelling the incidence of Plasmodium vivax and Plasmodium falciparum malaria in Afghanistan 2006-2009.
por: Victor A Alegana, et al.
Publicado: (2014)